Skip to main content
. 2020 Mar 3;29(5):451–457. doi: 10.1159/000506864

Table 1.

Demographic characteristics of the patients with or without cognitive impairment

Characteristics Cognitive impairment group (n = 139) Normal cognition group (n = 87) t/Z/χ2 value p
Male gender, n (%) 78 (56.1) 45 (51.7) 0.416 0.519
Age, years 65.0 [61.00, 71.00] 59.00 [51.00, 64.00] 5.508 0.000*
Lower education, n (%) 65 (46.8) 15 (17.2) 20.392 0.000*
Smoking, n (%) 45 (32.4) 18 (20.7) 3.634 0.057
Alcohol, n (%) 34 (24.5) 18 (20.7) 0.429 0.512
Stroke, n (%) 37 (26.6) 13 (14.9) 4.234 0.040*
Hypertension, n (%) 96 (69.1) 34 (39.1) 19.689 0.000*
Diabetes, n (%) 33 (23.7) 11 (11.5) 5.209 0.040*
Hyperlipemia, n (%) 66 (47.5) 40 (46.0) 0.001 0.979
Coronary disease, n (%) 30 (20.1) 10 (11.5) 3.739 0.053

TG, mmol/L 1.3 [1.00, 1.97] 1.29 [0.91, 1.95] 0.627 0.530
TC, mmol/L 4.7±1.04 4.52±0.98 1.797 0.074
LDL, mmol/L 2.5 [2.01, 3.04] 2.62 [2.20, 3.15] −1.066 0.286
HDL, mmol/L 1.1 [2.01, 3.04] 1.18 [1.06, 1.37] −1.909 0.056
Glucose, mmol/L 5.4 [4.97, 6.30] 5.38 [4.95, 5.86] 0.632 0.527
Systolic pressure, mm Hg 150.0 [136.0, 164.0] 137.0 [121.00, 152.00] 4.554 0.000*
Diastolic pressure, mm Hg 83.0 [76.0, 90.0] 83.0 [73.00, 93.00] 0.379 0.705
Hcy, μmol/L 13.0 [10.0, 17.0] 11.0 [9.00, 16.00] 2.366 0.018*
Uric acid, mmol/L 388.0 [340.0, 434.0] 334.0 [295.00, 398.00] 4.015 0.000*
25-(OH) D, ng/mL 15.44±5.71 21.44±7.17 −6.608 0.000*

Values are presented as n (%), mean ± standard deviation, or median [25th and 75th interquartile range]. LDL, low-density lipoprotein cholesterol; HDL, high-density lipoprotein cholesterol; TC, total cholesterol; TG, triglyceride; Hcy, homocysteine.

*

p < 0.05, for the pairwise comparison between the cognitive impairment group and normal cognition group.